佰金生命科学控股有限公司宣布，其子公司已与敷尔佳生物科技签署战略合作框架协议。
根据协议安排，北京佰金将负责研发、生产、质量控制和供应链管理。敷尔佳生物科技则将提供专业技术、专利资源及市场拓展能力。
此次合作将整合双方优势资源，共同推进生物科技领域的创新发展。
佰金生命科学控股有限公司宣布，其子公司已与敷尔佳生物科技签署战略合作框架协议。
根据协议安排，北京佰金将负责研发、生产、质量控制和供应链管理。敷尔佳生物科技则将提供专业技术、专利资源及市场拓展能力。
此次合作将整合双方优势资源，共同推进生物科技领域的创新发展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.